Clinical Trial Update: Pharmacodynamics and Non-Clinical Inferiority of Heparin Sodium (Cristália) Compared With the Product Liquemine (Roche) in Chronic Renal Failure [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting pharmacodynamics data and indicating inferiority of Cristália's heparin sodium compared with Roche's Liquemine in chronic kidney…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Renal Failure

Drugs mentioned

• HEPARIN SODIUM (HEPARIN SODIUM)
• Liquemine (heparin)

Snippet

Sponsor: Azidus Brasil | Conditions: Chronic Renal Failure | Phase 2, Phase 3 | Status: COMPLETED